Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,712,890 papers from all fields of science
Search
Sign In
Create Free Account
AT7519
Known as:
AT 7519
, AT-7519
, AT7519M
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
CDK inhibitor AT7519M
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The investigation of AT7519 (CDK inhibitor) and AT13387 (HSP90 inhibitor) as novel therapies for the treatment of pancreatic ductal adenocarcinoma
A. Thomas
2016
Corpus ID: 86559032
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is usually a systemic disease and so requires chemotherapy even when surgical…
Expand
2009
2009
Gateways to clinical trials.
A. Tomillero
,
M. A. Moral
Methods and Findings in Experimental and Clinical…
2009
Corpus ID: 40344481
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…
Expand
2008
2008
A dose escalation, pharmacokinetic, and pharmacodynamic study of AT7519, a cyclin-dependent kinase inhibitor in patients with refractory solid tumors
D. Mahadevan
,
R. Plummer
,
+7 authors
H. Calvert
2008
Corpus ID: 78990715
3533 Background: AT7519M is a structure-based rationally designed Nan molar small molecular Cyclin-dependent Kinase (CDK…
Expand